Small Molecule Discovery

From hit discovery to ADME/T prediction,
All in one place

From hit discovery to ADME/T prediction,
All in one place

Small Molecule Discovery

From hit discovery to ADME/T prediction,
All in one place

Explore vast space for Greater discovery success

  • Hyper Screening X searches a massive 11-trillion-compound virtual library to uncover novel and diverse molecules.

  • Efficiently navigate an expansive chemical space—unfeasible with traditional virtual screening—using cutting-edge generative AI.

  • The Hyper Screening X library continues to grow, expanding your discovery potential.

Find molecules tailored to your target

  • Why settle for the same AI? Hyper Screening X customizes the AI training to fit your project’s unique needs.

  • Define physicochemical conditions for molecules alongside the target protein.

  • Use trained AI models to generate condition-specific molecules as many times as needed.

Request synthesis quotes and Purchase Building Blocks

  • Easily get synthesis quotes for your generated molecules directly through HyperLab.

  • Browse building block prices, suppliers, and delivery times in one interface.

Leverage the power of the generative AI

  • Hyper Screening X is powered by RxnFlow, a state-of-the-art generative AI for molecule discovery [ICLR 2025].

  • RxnFlow constructs molecules by combining building blocks through chemical reactions, overcoming unnatural structures and low synthesizability issues common in traditional generative AI designs.

  • Flexibly train AI to generate molecules meeting complex conditions, even across countless possibilities.

* Seunghwan Seo et al. ICLR 2025 (arXiv:2410.04542).

Access building blocks and Synthesis routes

  • Hyper Screening X generates molecules using purchasable building blocks and feasible chemical reactions.

  • Generated molecules achieve over 80% synthesizability,* ensuring reliable synthesis outcomes.

* Validated by Synple Chem synthesis service.

Explore vast space for Greater discovery success

  • Hyper Screening X searches a massive 11-trillion-compound virtual library to uncover novel and diverse molecules.

  • Efficiently navigate an expansive chemical space—unfeasible with traditional virtual screening—using cutting-edge generative AI.

  • The Hyper Screening X library continues to grow, expanding your discovery potential.

Find molecules tailored to your target

  • Why settle for the same AI? Hyper Screening X customizes the AI training to fit your project’s unique needs.

  • Define physicochemical conditions for molecules alongside the target protein.

  • Use trained AI models to generate condition-specific molecules as many times as needed.

Request synthesis quotes and Purchase Building Blocks

  • Easily get synthesis quotes for your generated molecules directly through HyperLab.

  • Browse building block prices, suppliers, and delivery times in one interface.

Leverage the power of the generative AI

  • Hyper Screening X is powered by RxnFlow, a state-of-the-art generative AI for molecule discovery [ICLR 2025].

  • RxnFlow constructs molecules by combining building blocks through chemical reactions, overcoming unnatural structures and low synthesizability issues common in traditional generative AI designs.

  • Flexibly train AI to generate molecules meeting complex conditions, even across countless possibilities.

* Seunghwan Seo et al. ICLR 2025 (arXiv:2410.04542).

Access building blocks and Synthesis routes

  • Hyper Screening X generates molecules using purchasable building blocks and feasible chemical reactions.

  • Generated molecules achieve over 80% synthesizability,* ensuring reliable synthesis outcomes.

* Validated by Synple Chem synthesis service.

Explore vast space for Greater discovery success

  • Hyper Screening X searches a massive 11-trillion-compound virtual library to uncover novel and diverse molecules.

  • Efficiently navigate an expansive chemical space—unfeasible with traditional virtual screening—using cutting-edge generative AI.

  • The Hyper Screening X library continues to grow, expanding your discovery potential.

Find molecules tailored to your target

  • Why settle for the same AI? Hyper Screening X customizes the AI training to fit your project’s unique needs.

  • Define physicochemical conditions for molecules alongside the target protein.

  • Use trained AI models to generate condition-specific molecules as many times as needed.

Request synthesis quotes and Purchase Building Blocks

  • Easily get synthesis quotes for your generated molecules directly through HyperLab.

  • Browse building block prices, suppliers, and delivery times in one interface.

Leverage the power of the generative AI

  • Hyper Screening X is powered by RxnFlow, a state-of-the-art generative AI for molecule discovery [ICLR 2025].

  • RxnFlow constructs molecules by combining building blocks through chemical reactions, overcoming unnatural structures and low synthesizability issues common in traditional generative AI designs.

  • Flexibly train AI to generate molecules meeting complex conditions, even across countless possibilities.

* Seunghwan Seo et al. ICLR 2025 (arXiv:2410.04542).

Access building blocks and Synthesis routes

  • Hyper Screening X generates molecules using purchasable building blocks and feasible chemical reactions.

  • Generated molecules achieve over 80% synthesizability,* ensuring reliable synthesis outcomes.

* Validated by Synple Chem synthesis service.

Ready to revolutionize
Your drug discovery process?

Sign up with your email and start using HyperLab right now

HITS Inc.

CEO : Woo Youn Kim

Address : 8F, 28, Teheran-ro 4-gil, Gangnam-gu, Seoul, Republic of Korea

Tel : +82-2-6953-0317

Company registration number : 260-88-01818

© HITS Inc. All rights reserved.

Ready to revolutionize
Your drug discovery process?

Sign up with your email and start using HyperLab right now

HITS Inc.

CEO : Woo Youn Kim

Address : 8F, 28, Teheran-ro 4-gil, Gangnam-gu,
Seoul, Republic of Korea

Tel : +82-2-6953-0317

Company registration number : 260-88-01818

© HITS Inc. All rights reserved.

Ready to revolutionize
Your drug discovery process?

Sign up with your email and start using HyperLab right now

HITS Inc.

CEO : Woo Youn Kim

Address : 8F, 28, Teheran-ro 4-gil, Gangnam-gu, Seoul, Republic of Korea

Tel : +82-2-6953-0317

Company registration number : 260-88-01818

© HITS Inc. All rights reserved.